Citation Impact
Citing Papers
Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy
2012 StandoutNobel
Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis
2007 Standout
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
2007 StandoutScience
Targeted HER2 Treatment in Advanced Gastric Cancer
2010
Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
2021 StandoutNobel
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 Standout
The Correlation Between Cytoplasmic Overexpression of Epidermal Growth Factor Receptor and Tumor Aggressiveness
2004
Gastric cancer
2016 Standout
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2007 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
Pancreatic cancer
2004 Standout
Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
2004 Standout
Reactive Oxygen Species Promote TNFα-Induced Death and Sustained JNK Activation by Inhibiting MAP Kinase Phosphatases
2005 Standout
Chemoradiation for upper aerodigestive tract cancer: balancing evidence from clinical trials with individual patient recommendations
2003
Scavenging Peroxynitrite with Glutathione Promotes Regeneration and Enhances Survival during Acetaminophen-Induced Liver Injury in Mice
2003
Liver Regeneration
2006
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Signal integration by JNK and p38 MAPK pathways in cancer development
2009 Standout
Pancreatic cancer
2020 Standout
Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy
2008
Polymer-drug conjugates: Recent development in clinical oncology
2008
TLR4 enhances TGF-β signaling and hepatic fibrosis
2007 Standout
Prodrug Strategies in Anticancer Chemotherapy
2007
Production and Characterization of γ-Polyglutamic Acid Nanoparticles for Controlled Anticancer Drug Release
2008
Paclitaxel poliglumex for ovarian cancer
2011
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Rapid translocation of nanoparticles from the lung airspaces to the body
2010 StandoutNobel
Interleukin–10 Controls Neutrophilic Infiltration, Hepatocyte Proliferation, and Liver Fibrosis Induced by Carbon Tetrachloride in Mice
1998
NFkappaB prevents apoptosis and liver dysfunction during liver regeneration.
1998
Esophageal Cancer
2003 Standout
Detection of B7-H4 and p53 in Pancreatic Cancer
2008
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Polymer conjugates as anticancer nanomedicines
2006 Standout
Cytokines in non-genotoxic hepatocarcinogenesis
1999
IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy
2005 Standout
Design considerations for tumour-targeted nanoparticles
2009 StandoutNobel
Epigallocatechin-3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon tetrachloride (CCl4)-induced liver injury in mice
2010
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
2017 StandoutNobel
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Molecular prognostic markers in pancreatic cancer: A systematic review
2005
Liver regeneration
2007
Tuberous sclerosis
2008 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy
2006
Kupffer cell depletion abolishes induction of interleukin-10 and permits sustained overexpression of tumor necrosis factor alpha messenger RNA in the regenerating rat liver
1997
Intracellular Signaling Mechanisms of Acetaminophen-Induced Liver Cell Death
2005
Inflammation and cancer: back to Virchow?
2001 Standout
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
Consensus clinical guidelines for the assessment of cognitive and behavioural problems in Tuberous Sclerosis
2005
Inflammatory Cytokine TNFα Promotes the Long-Term Expansion of Primary Hepatocytes in 3D Culture
2018
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
2018 StandoutNobel
Role of Kupffer cells in host defense and liver disease
2006
Role of Kupffer cells and oxidants in signaling peroxisome proliferator-induced hepatocyte proliferation
2000
The Multifunctional Fish Gill: Dominant Site of Gas Exchange, Osmoregulation, Acid-Base Regulation, and Excretion of Nitrogenous Waste
2004 Standout
Pancreatic Cancer
2010 Standout
Hybrid nanoparticles for combination therapy of cancer
2015
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Liver Regeneration after Partial Hepatectomy
2009
Prospects for adoptive immunotherapy of pancreatic cancer using chimeric antigen receptor-engineered T-cells
2015
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Pancreatic cancer
2011 Standout
c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity
2006
Does Paclitaxel Improve the Chemoradiotherapy of Locoregionally Advanced Esophageal Cancer? A Nonrandomized Comparison With Fluorouracil-Based Therapy
2000
INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of Combined-Modality Therapy for Esophageal Cancer: High-Dose Versus Standard-Dose Radiation Therapy
2002
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Rapid activation of the stat3 transcription complex in liver regeneration
1995
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Nitric oxide and the immune response
2001 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Impaired liver regeneration in inducible nitric oxide synthasedeficient mice
1998
Liver regeneration versus direct hyperplasia
1996
Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning
2003
Liver Regeneration
1997 StandoutScience
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
Conjugated linoleic acid inhibits cell proliferation and ErbB3 signaling in HT-29 human colon cell line
2003
Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type I tumor necrosis factor receptor
1997
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials
2016
Tissue- and Organ-Selective Biodistribution of NIR Fluorescent Quantum Dots
2009 StandoutNobel
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Tissue-specific expression of B7x protects from CD4 T cell–mediated autoimmunity
2011 StandoutNobel
Proinflammatory Cytokine Production in Liver Regeneration Is Myd88-Dependent, but Independent of Cd14, Tlr2, and Tlr4
2006
Metastatic pancreatic cancer: Is gemcitabine still the best standard treatment? (Review)
2010
Clinical Translation of Nanomedicine
2015
Works of Paul Akerman being referenced
Overexpression of the HER-2/ neu Oncogene in Pancreatic Adenocarcinoma
2001
Paclitaxel Poliglumex (PPX-Xyotax) and Concurrent Radiation for Esophageal and Gastric Cancer
2006
Erlotinib and Chemoradiation Followed by Maintenance Erlotinib for Locally Advanced Pancreatic Cancer
2005
Incidence of arrhythmia with central venous catheter insertion and exchange
1990
Paclitaxel, Cisplatin, and Concurrent Radiation for Esophageal Cancer
2001
Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction.
1999
Herceptin and gemcitabine for metastatic pancreatic cancers that overexpress HER-2/neu
2001
Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy
1992
Paclitaxel poliglumex (PPX) and concurrent radiation for treatment of patients with esophageal or gastric cancer: A dose-ranging study
2005